CVS Health (CVS) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $79.96 -12.53%
Financial Fact:
Operating expenses: 4.68B
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Operating expenses: 4.68B
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $1.33, $0.02 better than the analyst estimate of $1.31. Revenue for the quarter came in at $45.7 billion versus the consensus estimate of $45.37 billion.
Comps decline 2.6%
GUIDANCE:
CVS Health sees FY2017 EPS of $5.83-$5.93, versus the consensus of $5.87.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Socket Mobile (SCKT) Reports Q3 Loss of $0.09
- Enact Holdings (ACT) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
